These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 18369199)

  • 1. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis.
    Yende S; D'Angelo G; Kellum JA; Weissfeld L; Fine J; Welch RD; Kong L; Carter M; Angus DC;
    Am J Respir Crit Care Med; 2008 Jun; 177(11):1242-7. PubMed ID: 18369199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.
    Kellum JA; Kong L; Fink MP; Weissfeld LA; Yealy DM; Pinsky MR; Fine J; Krichevsky A; Delude RL; Angus DC;
    Arch Intern Med; 2007 Aug 13-27; 167(15):1655-63. PubMed ID: 17698689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of age on inflammatory and coagulation-fibrinolysis response in patients hospitalized for pneumonia.
    Kale S; Yende S; Kong L; Perkins A; Kellum JA; Newman AB; Vallejo AN; Angus DC;
    PLoS One; 2010 Nov; 5(11):e13852. PubMed ID: 21085465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Red Cell Distribution Width During Hospitalization for Community-Acquired Pneumonia: Clinical Characteristics and Prognostic Significance.
    Gorelik O; Izhakian S; Barchel D; Almoznino-Sarafian D; Tzur I; Swarka M; Beberashvili I; Feldman L; Cohen N; Shteinshnaider M
    Lung; 2016 Dec; 194(6):985-995. PubMed ID: 27650510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of age and comorbidities on serum levels of inflammatory markers in community-acquired pneumonia.
    Viasus D; Simonetti AF; Estupiñan-Bohórquez AF; Carratalà J
    Eur J Clin Invest; 2021 Jun; 51(6):e13480. PubMed ID: 33350464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 at discharge predicts all-cause mortality in patients with sepsis.
    Naffaa M; Makhoul BF; Tobia A; Kaplan M; Aronson D; Saliba W; Azzam ZS
    Am J Emerg Med; 2013 Sep; 31(9):1361-4. PubMed ID: 23896015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ.
    Zobel K; Martus P; Pletz MW; Ewig S; Prediger M; Welte T; Bühling F;
    BMC Pulm Med; 2012 Feb; 12():6. PubMed ID: 22348735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response.
    Tejera A; Santolaria F; Diez ML; Alemán-Valls MR; González-Reimers E; Martínez-Riera A; Milena-Abril A
    Cytokine; 2007 Jun; 38(3):117-23. PubMed ID: 17659879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis.
    Angus DC; Yang L; Kong L; Kellum JA; Delude RL; Tracey KJ; Weissfeld L;
    Crit Care Med; 2007 Apr; 35(4):1061-7. PubMed ID: 17334246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.
    Antunes G; Evans SA; Lordan JL; Frew AJ
    Eur Respir J; 2002 Oct; 20(4):990-5. PubMed ID: 12412694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?
    Dremsizov T; Clermont G; Kellum JA; Kalassian KG; Fine MJ; Angus DC
    Chest; 2006 Apr; 129(4):968-78. PubMed ID: 16608946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths.
    Yende S; D'Angelo G; Mayr F; Kellum JA; Weissfeld L; Kaynar AM; Young T; Irani K; Angus DC;
    PLoS One; 2011; 6(8):e22847. PubMed ID: 21853050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of N-terminal pro-brain natriuretic peptide in hospitalised patients with community-acquired pneumonia.
    Jeong KY; Kim K; Kim TY; Lee CC; Jo SO; Rhee JE; Jo YH; Suh GJ; Singer AJ
    Emerg Med J; 2011 Feb; 28(2):122-7. PubMed ID: 20511643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study.
    Laterre PF; Garber G; Levy H; Wunderink R; Kinasewitz GT; Sollet JP; Maki DG; Bates B; Yan SC; Dhainaut JF;
    Crit Care Med; 2005 May; 33(5):952-61. PubMed ID: 15891319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.
    Yandiola PPE; Capelastegui A; Quintana J; Diez R; Gorordo I; Bilbao A; Zalacain R; Menendez R; Torres A
    Chest; 2009 Jun; 135(6):1572-1579. PubMed ID: 19141524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia.
    Lee YL; Chen W; Chen LY; Chen CH; Lin YC; Liang SJ; Shih CM
    J Crit Care; 2010 Mar; 25(1):176.e7-13. PubMed ID: 19592208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?
    Kelly E; MacRedmond RE; Cullen G; Greene CM; McElvaney NG; O'Neill SJ
    Respirology; 2009 Mar; 14(2):210-6. PubMed ID: 19272082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis.
    Romagnoli C; Frezza S; Cingolani A; De Luca A; Puopolo M; De Carolis MP; Vento G; Antinori A; Tortorolo G
    Eur J Pediatr; 2001 Jun; 160(6):345-50. PubMed ID: 11421413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are pre-existing markers of chronic kidney disease associated with short-term mortality following acute community-acquired pneumonia and sepsis? A cohort study among older people with diabetes using electronic health records.
    McDonald HI; Nitsch D; Millett ER; Sinclair A; Thomas SL
    Nephrol Dial Transplant; 2015 Jun; 30(6):1002-9. PubMed ID: 25605811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-To-Lymphocyte Ratio: An Emerging Marker Predicting Prognosis in Elderly Adults with Community-Acquired Pneumonia.
    Cataudella E; Giraffa CM; Di Marca S; Pulvirenti A; Alaimo S; Pisano M; Terranova V; Corriere T; Ronsisvalle ML; Di Quattro R; Stancanelli B; Giordano M; Vancheri C; Malatino L
    J Am Geriatr Soc; 2017 Aug; 65(8):1796-1801. PubMed ID: 28407209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.